CPHA Canvax

"As of August 17, 2020, SARS-CoV-2 has been associated with more than 5.3 million infections and more than 168 000 deaths in the US.2 Even a moderately severe influenza season in the presence of circulating SARS-CoV-2 would significantly amplify cases of acute respiratory illness, and more intensely stress health care personnel and resources, including hospitals, emergency departments, outpatient departments, and physicians’ offices.

However, less than half of US adults receive an influenza vaccine each year (Table). Even after the severe 2017-2018 influenza season, overall vaccine coverage remained at about 45% during the subsequent (2018-2019) season, and long-standing and substantial disparities, particularly by race and ethnicity, persisted in estimated coverage. Specifically, vaccine coverage estimates remained substantially lower for non-Hispanic Black, Hispanic, and American Indian/Alaskan Native adults relative to non-Hispanic White adults (Table)." - Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic

Rating See Comments Ratings


Monitoring and Surveillance,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals,Outbreaks and Pandemics,COVID-19,Vaccine Preventable Diseases,Communicable Diseases,Influenza Monitoring and Surveillance
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Outbreaks and Pandemics
Vaccine Preventable Diseases
Communicable Diseases


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.